Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −9 vs. Q2 2024
- Shares held
- 5.19M
- −699.1K (−11.9%) vs. Q2 2024
- Total value
- $4.04M
- −$374.0K (−8.5%) vs. Q2 2024
- New holders
- 3
- 10 more added
- Sold out
- 12
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,199,648 | $930.9K | 0.00% | −14,973−1.2% | Reduced |
| EPIQ Capital Group, LLC | 825,942 | $641.1K | 0.18% | −26,419−3.1% | Reduced |
| Renaissance Technologies LLC | 522,576 | $405.6K | 0.00% | +38,674+8.0% | Added |
| Almitas Capital LLC | 382,882 | $297.2K | 0.11% | +382,882 | New |
| BlackRock, Inc. | 358,358 | $278.2K | 0.00% | +358,358 | New |
| HighTower Advisors, LLC | 341,570 | $273.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 339,125 | $263.3K | 0.00% | +66,170+24.2% | Added |
| Alphabet Inc. | 189,122 | $147.5K | 0.01% | 00.0% | Unchanged |
| Shay Capital LLC | 172,183 | $133.6K | 0.04% | +172,183 | New |
| Bank of America Corp | 157,978 | $122.6K | 0.00% | +60.0% | Added |
| ADAR1 Capital Management, LLC | 142,958 | $111.0K | 0.02% | +50,000+53.8% | Added |
| Mariner, LLC | 122,461 | $95.1K | 0.00% | +48,387+65.3% | Added |
| Citadel Advisors LLC | 107,007 | $83.1K | 0.00% | +7,163+7.2% | Added |
| Bridgeway Capital Management, LLC | 88,495 | $68.7K | 0.00% | −50,000−36.1% | Reduced |
| State Street Corp | 56,611 | $43.9K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,527 | $41.5K | 0.01% | +215+0.4% | Added |
| Northern Trust Corp | 34,023 | $26.4K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 32,553 | $25.3K | 0.00% | −66,050−67.0% | Reduced |
| XTX Topco Ltd | 21,570 | $16.7K | 0.00% | +7,493+53.2% | Added |
| Citigroup Inc | 17,127 | $13.3K | 0.00% | +11,962+231.6% | Added |
| Nixon Peabody Trust Co | 11,126 | $8.64K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,522 | $6.62K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,549 | $4.31K | 0.00% | −4,069−42.3% | Reduced |
| JPMorgan Chase & Co | 548 | $425 | 0.00% | +79+16.8% | Added |
| UBS Group AG | 480 | $373 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 431 | $335 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $264 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $241 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $229 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $216 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $78 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $78 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $58 | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −93,600−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,567−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −15,359−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −11,013−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −10,136−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −10,136−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,101−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −394−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −279−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |